Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON51705
NL-OMON51705
Not yet recruiting
Not Applicable

*MR PulmonalIsangiografie ter veRvanging vAn CT- Pulmonalisangiografie bij patiënten met de klinische verdenking op LongEmbolie; de MIRACLE studie* - MIRACLE studie

oordwest Ziekenhuisgroep0 sites272 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsbloedprop in de longvatenlongembolieën1003745410014523

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
bloedprop in de longvaten
Sponsor
oordwest Ziekenhuisgroep
Enrollment
272
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
oordwest Ziekenhuisgroep

Eligibility Criteria

Inclusion Criteria

  • •Wilsbekwaam

Exclusion Criteria

  • •Reguliere exclusiecriteria voor MR\-onderzoek,
  • •Contrastallergie,
  • •Hemodynamische instabiliteit,
  • •Ernstige respiratoire insufficiëntie
  • •Immobiele patiënt.\*
  • •Zwangerschap
  • •Dialysepatiënten
  • •COVID\-19 positieve patiënten

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study to evaluate how does the weight and height of a patient affect the brightness of a blood vessel on giving a dye in a CT scan which is done to look for blockage of the blood vessels of the lungs.
CTRI/2011/09/002021DR SUPREETA ARYA70
Not yet recruiting
Not Applicable
To Assess CT Chest finding of Post-covid Pneumonia Patient
CTRI/2020/12/029733Dr Nil Patel
Not yet recruiting
Not Applicable
Evaluation of pulmonary nodules by using CT perfusion techniquepulmonary nodular lesion
JPRN-UMIN000002690Department of Diagnostic Radiology, Saitama Medical University International Medical Center60
Completed
Not Applicable
A randomised, double blinded, placebo controlled trial of the effect of self administered methoxyflurane using the Penthrox® Inhaler on tolerance of the Computed Tomography (CT) Enteroclysis procedureCT enteroclysis toleranceOral and Gastrointestinal - Inflammatory bowel disease
ACTRN12608000058370Dr Alan Moss, Principal Investigator, Penthrox for CTE trial60
Completed
Not Applicable
[18F]-FDG PET/CT to image pulmonary inflammation in critically-ill patients with COVID-19 ARDS *The PET-COV study*COVID-191004743810024970
NL-OMON51430niversitair Medisch Centrum Groningen70